Dual-time-point F-18 FDG PET/CT for evaluation in patients with malignant lymphoma
- 13 June 2012
- journal article
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 26 (8) , 616-621
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Dual-Time F-18 FDG-PET/CT Imaging for Diagnosis of Occult Non-Hodgkin Lymphoma in a Patient With Esophageal CancerClinical Nuclear Medicine, 2009
- The usefulness of 18F‐fluorodeoxyglucose positron emission tomography (18F‐FDG‐PET) and a comparison of 18F‐FDG‐pet with 67gallium scintigraphy in the evaluation of lymphomaCancer, 2007
- Delayed [18F]FDG PET imaging of central nervous system lymphoma: is PET better than MRI?European Journal of Nuclear Medicine and Molecular Imaging, 2006
- Role of fluorine‐18 fluoro‐deoxyglucose positron emission tomography scan in the evaluation and follow‐up of patients with low‐grade lymphomasCancer, 2006
- 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of gradingAnnals of Oncology, 2006
- A metaanalysis of 18F‐2‐deoxy‐2‐fluoro‐D‐glucose positron emission tomography in the staging and restaging of patients with lymphomaCancer, 2005
- Utility of FDG-PET scanning in lymphoma by WHO classificationBlood, 2003
- Advantage of delayed whole-body FDG-PET imaging for tumour detectionEuropean Journal of Nuclear Medicine and Molecular Imaging, 2001
- Delayed18F-fluoro-2-deoxy-D-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreasCancer, 2000
- Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neckEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999